Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Test Viropro's Cell-Development, Protein Technologies

NEW YORK (GenomeWeb News) — Invitrogen and Viropro have signed an R&D agreement in which Invitrogen will test protein-production techniques and cell-development technology developed by Viropro, Viropro said today.
 
Viropro, based in Montreal, also said the deal allows the company the opportunity to out-license the combined technology and make intellectual property deals with biotech companies looking to integrate the IP into their own research and production processes.
 
Jeff Greenberg, vice president of Invitrogen's BioProduction business, said the company is "enthusiastic about testing this new technology and hope to establish a long-term relationship with Viropro."

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.